PF-Atlas › Исследования › STAT News
Исследования: STAT News (21)
21 публикаций в теме «STAT News», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says · STAT News · 2026
- STAT+: Closely watched Pfizer lung cancer drug falls short in clinical trial · STAT News · 2026
- What is pulmonary hypertension and why would a new GLP-1 help? · STAT News · 2026
- STAT+: Roche drug sets new standard for KRAS-driven lung cancer · STAT News · 2026
- Martha Lillard, last U.S. polio patient using iron lung, dies at 78 in Oklahoma · STAT News · 2026
- STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims · STAT News · 2026
- STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial · STAT News · 2026
- STAT+: Skylark Bio kicks off new gene therapy trial for deafness · STAT News · 2026
- STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit · STAT News · 2026
- STAT+: FDA approves Ultragenyx gene therapy · STAT News · 2026
- STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more · STAT News · 2026
- STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns · STAT News · 2026
- STAT+: We’re reading about an Ultragenyx failure, RevMed for lung cancer, and more · STAT News · 2026
- Opinion: STAT+: A surprising bright spot at the FDA on regulating unproven stem cells · STAT News · 2026
- STAT+: Roivant lung disease drug hits mid-stage study goals · STAT News · 2026
- STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout · STAT News · 2026
- STAT+: FDA expands Bayer lung cancer drug approval · STAT News · 2026
- STAT+: GSK touts lung cancer data from two drugs · STAT News · 2026
- STAT+: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease · STAT News · 2026
- STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factor · STAT News · 2026
- STAT+: FDA reverses course on Regenxbio’s childhood gene therapy after rejection · STAT News · 2026
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.